跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,172 条关于
“Kaerus Bioscience”
全部
2,172
临床试验
434
药物
471
机构
286
资讯
981
去年
Kaerus Bioscience's KER-0193 Receives FDA Orphan and Rare Pediatric Drug Designations for Fragile X Syndrome
去年
Servier Acquires KER-0193 for $450M to Target Fragile X Syndrome, Marking First Neurology Asset
去年
Skye Bioscience Advances Nimacimab into Phase 2 Obesity Trial
去年
Daré Bioscience Advances Sildenafil Cream for Female Sexual Arousal Disorder
3个月前
SK Bioscience Partners with Colombia on $260 Million Vaccine Manufacturing Initiative
去年
SK Bioscience Wins Appeal Against Pfizer in Pneumococcal Vaccine Patent Dispute
9个月前
Niagen Bioscience Acquires Core NAD+ Patent Portfolio from Queen's University Belfast
14天前
KKR to Sell Minority Stake in Nordic Bioscience to Founder Claus Christiansen
去年
SK Bioscience Wins Patent Dispute Against Pfizer Over Pneumococcal Vaccine Components
去年
Jord BioScience Raises Series B Funding to Advance Agricultural Microbial Solutions
第 1 页,共 99 页
上一页
下一页